|
[1]
|
Yigitler, C., Gulec, B., Aydogan, H., Ozcan, A., Kilinc, M., Yigit, T., et al. (2004) Effect of Mesalazine, Metronidazole and Gentamicin on Bacterial Translocation in Experimental Colitis. Journal of Gastroenterology and Hepatology, 19, 1179-1186.[CrossRef] [PubMed]
|
|
[2]
|
Koelink, P.J., Mieremet-Ooms, M.A.C., Corver, W.E., Wolanin, K., Hommes, D.W., Lamers, C.B.H.W., et al. (2010) 5-Aminosalicylic Acid Interferes in the Cell Cycle of Colorectal Cancer Cells and Induces Cell Death Modes. Inflammatory Bowel Diseases, 16, 379-389.[CrossRef] [PubMed]
|
|
[3]
|
Brown, W.A., Farmer, K.C., Skinner, S.A., Malcontenti-Wilson, C., Misajon, A. and O’Brien, P.E. (2000) 5-Aminosalicylic Acid and Olsalazine Inhibit Tumor Growth in a Rodent Model of Colorectal Cancer. Digestive Diseases and Sciences, 45, 1578-1584.[CrossRef]
|
|
[4]
|
Avdeef, A. (2001) Physicochemical Profiling (Solubility, Permeability and Charge State). Current Topics in Medicinal Chemistry, 1, 277-351. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Rachmilewitz, D. (1989) Coated Mesalazine (5-Aminosalicylic Acid) versus Sulphasalazine in the Treatment of Active Ulcerative Colitis: A Randomised Trial. British Medical Journal, 298, 82-86.[CrossRef] [PubMed]
|
|
[6]
|
Bardineshin, F., Bahramikia, S., Khodarahmi, R. and Hadi, F. (2023) Mesalazine Inhibits Amyloid Formation and Destabilizes Pre-Formed Amyloid Fibrils in the Human Insulin. Journal of Fluorescence, 33, 1317-1324.
|
|
[7]
|
Rousseaux, C., Lefebvre, B., Dubuquoy, L., Lefebvre, P., Romano, O., Auwerx, J., et al. (2005) Intestinal Antiinflammatory Effect of 5-Aminosalicylic Acid Is Dependent on Peroxisome Proliferator-Activated Receptor-γ. The Journal of Experimental Medicine, 201, 1205-1215.[CrossRef] [PubMed]
|
|
[8]
|
Talley, N.J., Abreu, M.T., Achkar, J., Bernstein, C.N., Dubinsky, M.C., Hanauer, S.B., et al. (2011) An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease. American Journal of Gastroenterology, 106, S2-S25.[CrossRef] [PubMed]
|
|
[9]
|
Abdolmohammad-Zadeh, H. and Kohansal, S. (2012) Determination of Mesalamine by Spectrofluorometry in Human Serum after Solid-Phase Extraction with Ni-Al Layered Double Hydroxide as a Nanosorbent. Journal of the Brazilian Chemical Society, 23, 473-481.[CrossRef]
|
|
[10]
|
French, D.L. and Mauger, J.W. (1993) Evaluation of the Physicochemical Properties and Dissolution Characteristics of Mesalamine: Relevance to Controlled Intestinal Drug Delivery. Pharmaceutical Research, 10, 1285-1290.[CrossRef] [PubMed]
|
|
[11]
|
Hanaee, J., Jouyban, A., Dastmalchi, S., Adibkia, K., Mirzazadeh, A. and Barzegar-Jalali, M. (2005) Solubility Prediction of Sulfonamides at Various Temperatures Using a Single Determination. DARU Journal of Pharmaceutical Sciences, 13, 37-45.
|
|
[12]
|
Martínez, F., Peña, M.Á. and Bustamante, P. (2011) Thermodynamic Analysis and Enthalpy-Entropy Compensation for the Solubility of Indomethacin in Aqueous and Non-Aqueous Mixtures. Fluid Phase Equilibria, 308, 98-106.[CrossRef]
|
|
[13]
|
Li, P., Tabibi, S.E. and Yalkowsky, S.H. (1999) Solubilization of Flavopiridol by pH Control Combined with Cosolvents, Surfactants, or Complexants. Journal of Pharmaceutical Sciences, 88, 945-947.[CrossRef] [PubMed]
|
|
[14]
|
Lima, I.B.C., Moreno, L.C.G.A.I., Peres, A.V., Santana, A.C.G., Carvalho, A., Chaves, M.H., et al. (2022) Nanoparticles Obtained from Zein for Encapsulation of Mesalazine. Pharmaceutics, 14, Article 2830.[CrossRef] [PubMed]
|
|
[15]
|
Tang, P., Sun, Q., Zhao, L., Pu, H., Yang, H., Zhang, S., et al. (2018) Mesalazine/Hydroxypropyl-β-Cyclodextrin/Chitosan Nanoparticles with Sustained Release and Enhanced Anti-Inflammation Activity. Carbohydrate Polymers, 198, 418-425.[CrossRef] [PubMed]
|
|
[16]
|
Aib, S., Iqbal, K., Khan, N., Khalid, S., Adnan, M., Umair, S.M., et al. (2022) Ph-Sensitive Liposomes for Colonic Co-Delivery of Mesalazine and Curcumin for the Treatment of Ulcerative Colitis. Journal of Drug Delivery Science and Technology, 72, Article 103335.[CrossRef]
|
|
[17]
|
Ha, E.-S., Kuk, D.-H., Kim, J.-S. and Kim, M.-S. (2019) Solubility of trans-Resveratrol in Transcutol HP + Water Mixtures at Different Temperatures and Its Application to Fabrication of Nanosuspensions. Journal of Molecular Liquids, 281, 344-351.[CrossRef]
|
|
[18]
|
Jouyban, A. (2019) Review of the Cosolvency Models for Predicting Drug Solubility in Solvent Mixtures: An Update. Journal of Pharmacy & Pharmaceutical Sciences, 22, 466-485.[CrossRef] [PubMed]
|
|
[19]
|
Moradi, M., Rahimpour, E., Hemmati, S., Martinez, F., Barzegar-Jalali, M. and Jouyban, A. (2020) Solubility of Mesalazine in Polyethylene Glycol 400 + Water Mixtures at Different Temperatures. Journal of Molecular Liquids, 314, Article 113546.[CrossRef]
|
|
[20]
|
Jouyban-Gharamaleki, V., Rahimpour, E., Hemmati, S., Martinez, F. and Jouyban, A. (2020) Mesalazine Solubility in Propylene Glycol and Water Mixtures at Various Temperatures Using a Laser Monitoring Technique. Journal of Molecular Liquids, 299, Article 112136.[CrossRef]
|
|
[21]
|
Rahimpour, E., Martinez, F., Hemmati, S., Ramezani, A.M. and Jouyban, A. (2022) Study of Mesalazine Solubility in Ternary Mixtures of Ethanol, Propylene Glycol, and Water at Various Temperatures. Journal of Pharmaceutical Sciences, 111, 2758-2764.[CrossRef] [PubMed]
|
|
[22]
|
Mazaher Haji Agha, E., Barzegar-Jalali, M., Adibkia, K., Hemmati, S., Kuentz, M., Martinez, F., et al. (2020) Solubility of Mesalazine in {1-Propanol/water} Mixtures at Different Temperatures. Journal of Molecular Liquids, 301, Article 112436.[CrossRef]
|
|
[23]
|
Zarghampour, A., Moradi, M., Martinez, F., Hemmati, S., Rahimpour, E. and Jouyban, A. (2021) Solubility Study of Mesalazine in the Aqueous Mixtures of a Deep-Eutectic Solvent at Different Temperatures. Journal of Molecular Liquids, 336, Article 116300.[CrossRef]
|
|
[24]
|
Jouyban, K., Mazaher Haji Agha, E., Hemmati, S., Martinez, F., Kuentz, M. and Jouyban, A. (2020) Solubility of 5-Aminosalicylic Acid in N-Methyl-2-Pyrrolidone + Water Mixtures at Various Temperatures. Journal of Molecular Liquids, 310, Article 113143.[CrossRef]
|
|
[25]
|
Jouyban, A. (2007) Prediction of Drug Solubility in Water-Propylene Glycol Mixtures Using Jouyban-Acree Model. Pharmazie, 62, 365-367.
|
|
[26]
|
Jouyban-Gharamaleki, V., Martinez, F., Kuentz, M., Rahimpour, E. and Jouyban, A. (2023) Using a Laser Monitoring Technique for Dissolution and Thermodynamic Study of Celecoxib in 2-Propanol and Propylene Glycol Mixtures. Dissolution Technologies, 30, 80-86.[CrossRef]
|
|
[27]
|
Tinjacá, D.A., Martinez, F., Almanza, O.A., Jouyban, A. and Acree, W.E. (2021) Solubility, Correlation, Dissolution Thermodynamics and Preferential Solvation of Meloxicam in Aqueous Mixtures of 2-Propanol. Pharmaceutical Sciences, 28, 130-144.[CrossRef]
|
|
[28]
|
Grodowska, K. and Parczewski, A. (2010) Organic Solvents in the Pharmaceutical Industry. Acta Poloniae Pharmaceutica, 67, 3-12.
|
|
[29]
|
Zheng, M., Han, J., Ma, J., Liang, J. and Zhao, H. (2019) Solubility and Preferential Solvation of Flubendazole Dissolved in Aqueous Co-Solvent Mixtures of 1,4-Dioxane, Dimethyl Sulfoxide, N,N-Dimethylformamide and Isopropanol. The Journal of Chemical Thermodynamics, 135, 225-232.[CrossRef]
|
|
[30]
|
Barzegar-Jalali, M., Mazaher Haji Agha, E., Adibkia, K., Martinez, F., Kuentz, M. and Jouyban, A. (2020) Solubility of Ketoconazole in 1,4-Dioxane + Water Mixtures at T = (293.2 to 313.2) K. Journal of Molecular Liquids, 306, Article 112830.[CrossRef]
|
|
[31]
|
Martin, A.N. and Sinko, P.J. (2011) Martin’s Phycical Pharmacy and Pharmaceutical Sciences, Physical Chemical and Biopharmaceutical Principles in the Pharmaceutical Sciences. Lippincott Williams & Wilkins.
|
|
[32]
|
Jouyban, A. and Fakhree, M.A.A. (2012) Experimental and Computational Methods Pertaining to Drug Solubility. In: Acree, B., Ed., Toxicity and Drug Testing, IntechOpen, 187-218.[CrossRef]
|
|
[33]
|
Jouyban, A. (2010) Handbook of Solubility Data for Pharmaceuticals. CRC Press Taylor & Francis Group.[CrossRef]
|
|
[34]
|
Williams, N.A. and Amidon, G.L. (1984) Excess Free Energy Approach to the Estimation of Solubility in Mixed Solvent Systems I: Theory. Journal of Pharmaceutical Sciences, 73, 9-13.[CrossRef] [PubMed]
|
|
[35]
|
Knox, C., Wilson, M., Klinger, C.M., Franklin, M., Oler, E., Wilson, A., et al. (2023) Drugbank 6.0: The Drugbank Knowledgebase for 2024. Nucleic Acids Research, 52, D1265-D1275.[CrossRef] [PubMed]
|
|
[36]
|
DiStefano, F.V. (2006) Molecules with Complexing Groups for Aqueous Nanoparticle Dispersions and Uses Thereof. CN Patent No. 101296744A.
https://patents.google.com/patent/CN101296744A/en
|
|
[37]
|
Zhu, T. and Van Voorhis, T. (2020) Understanding the Dipole Moment of Liquid Water from a Self-Attractive Hartree Decomposition. The Journal of Physical Chemistry Letters, 12, 6-12.[CrossRef] [PubMed]
|
|
[38]
|
Malmberg, C.G. and Maryott, A.A. (1956) Dielectric Constant of Water from 0˚ to 100˚C. Journal of Research of the National Bureau of Standards, 56, 1-8.[CrossRef]
|
|
[39]
|
Foroughi, H., Rahimpour, E., Kouhkan, M., Fathi Azarbayjani, A. and Jouyban, A. (2023) Solubility Enhancement of Atorvastatin Calcium and Ethanol-Mediated Transition with Some Surfactants. Physics and Chemistry of Liquids, 61, 285-290.[CrossRef]
|
|
[40]
|
Poturcu, K., Zarghampour, A., Rahimpour, E., Hemmati, S., Zhao, H. and Jouyban, A. (2023) Solubility and Thermodynamic Study of Mesalazine in Propylene Glycol + 2-Propanol Mixtures. Brazilian Journal of Chemical Engineering, 40, 1227-1238.[CrossRef]
|